Clinical trial

Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's…

NCT00002905 · Centro di Riferimento Oncologico - Aviano, Other · Unknown status

Key facts

NCT number NCT00002905
Title Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
Official title PROSPECTIVE NON-RANDOMIZED STUDY WITH CHEMOTHERAPY FOR RELAPSED OR REFRACTORY HIV-RELATED NON-HODGKIN'S LYMPHOMA: VMP REGIMEN FOR RELAPSED PATIENTS, CDE REGIMEN FOR REFRACTORY PATIENTS
Lead sponsor Centro di Riferimento Oncologico - Aviano, Other
Status Unknown status
Phase Phase 2
Study type Interventional
Conditions Lymphoma
Intervention type Drug
Interventions cyclophosphamide, didanosine, doxorubicin hydrochloride, etoposide, mitoxantrone hydrochloride, prednimustine, zidovudine
Enrollment 20
Start date Jun 1, 1995
First posted Jun 9, 2004
Last update posted Sep 20, 2013
Countries Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies